Sort   by:  
 Page size 
UnknownArginase 1 is a key driver of immune suppression in pancreatic cancer.
Not available
S-EPMC10260021 | biostudies-literature
UnknownCyst fluid metabolites distinguish malignant from benign pancreatic cysts.
Not available
S-EPMC8479274 | biostudies-literature
UnknownApolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB-Mediated Production of CXCL1.
Not available
S-EPMC8445065 | biostudies-literature
UnknownEWS-FLI1 and Menin Converge to Regulate ATF4 Activity in Ewing Sarcoma.
Not available
S-EPMC8462528 | biostudies-literature
UnknownPancreatic tumors exhibit myeloid-driven amino acid stress and upregulate arginine biosynthesis.
Not available
S-EPMC10260022 | biostudies-literature
UnknownRegulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis.
Not available
S-EPMC7224338 | biostudies-literature
UnknownPancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages.
Not available
S-EPMC8091600 | biostudies-literature
UnknownTumor cell death by ferroptosis contributes to an immunosuppressive tumor microenvironment in syngeneic murine models of cancer.
Not available
S-EPMC12803264 | biostudies-literature
UnknownCombinatorial Gli activity directs immune infiltration and tumor growth in pancreatic cancer.
Not available
S-EPMC9348714 | biostudies-literature
UnknownMetabolic requirement for GOT2 in pancreatic cancer depends on environmental context.
Not available
S-EPMC9328765 | biostudies-literature
Sort   by:  
 Page size